Congratulations to Our 2023 Team Science Awardees!
Congratulations to the 2023 Team Science Awardees! We are pleased to announce the 2023 recipients of the Johns Hopkins Institute for Clinical and Translational Research
New Findings About Key Pathological Protein in Parkinson’s Disease Open Paths to Novel Therapies
Findings focus on alpha-synuclein and its role in killing brain cells Second row shows how rapamycin dampens alpha-synuclein protein production in a magnified area of
New Study Advances Search for Accurate Blood Markers for Acute Kidney Injury
Findings seen as a step toward ending need for invasive kidney biopsies to predict AKI, and to help manage and assess treatment of serious kidney
The Research Navigator’s Corner- December 2023
The Navigators regularly receive questions covering a wide range of topics about conducting research studies at Johns Hopkins. It is not uncommon for multiple investigators
A Cure for Sickle Cell Disease
Sickle cells. Credit: adobe iStock A national, multicenter clinical trial (BMT CTN 1507) of low-dose haploidentical (half-matched) bone marrow transplant to treat severe sickle cell
Black Individuals More Likely to Experience Inequities in Early Diagnosis and Treatment of Lyme Disease, New Research Shows
An example of how the rash commonly associated with Lyme disease, erythema migrans, presents in different individuals. Credit: John Aucott, M.D., Johns Hopkins Medicine
ICTR in the News: Barbara Slusher, MD, MAS Developing Treatment for Inflammatory Bowel Disease
This article discusses the work of Barbara Slusher, PhD, MAS, director of Johns Hopkins Drug Discovery, and co-leader of the ICTR Drug, Biologics, Vaccines and Devices Translational Research Community.
Antibody Reduces Allergic Reactions to Multiple Foods in NIH Trial
Article courtesy of the NIH A monoclonal antibody treatment significantly increased the amounts of multiple common foods that food-allergic children and adolescents could consume without
Liquid Biopsy Predicts Immunotherapy Response and Toxicity in Patients with Advanced Lung Cancer
Using a “liquid biopsy” to study genetic material from tumors shed into the bloodstream together with immune cells could help clinicians predict which patients with
Study Suggests Serotonin Loss May Contribute to Cognitive Decline in the Early Stages of Alzheimer’s Disease
Comparing PET scans of more than 90 adults with and without mild cognitive impairment (MCI), Johns Hopkins Medicine researchers say relatively lower levels of the
Study Affirms Benefit of Very Early Antiretroviral Therapy Within Hours of Birth for Newborns with HIV
A study of more than 50 babies through age 2 in Africa, Asia, North America and South America has added substantially to evidence that giving
Experimental Drug Combination Shows Promise Against Hard-to-Treat Peripheral Nerve Sheath Tumors
Combining a pair of experimental drugs may help treat malignant peripheral nerve sheath tumors with fewer harmful side effects, according to preliminary animal studies
Excess Thyroid Hormone Levels Associated with Higher Risk of Cognitive Disorders Among Older Adults
A Johns Hopkins Medicine study has linked thyrotoxicosis to an increased risk of cognitive disorders among older adults. The researchers are encouraging clinicians to practice
Apply to the NCATS/FDA Translational Science Interagency Fellowship by January 15
Program Fact Sheet Apply The Translational Science Interagency Fellowship (TSIF) is a postdoctoral fellowship opportunity developed by the National Center for Advancing Translational Sciences (NCATS)
